PTGS2 and lung adenocarcinoma: These observations correlate with previous works that demonstrated a positive relationship between the expression of COX-2 and PD-L1 and a high number of metastatic events to lymph nodes in lung adenocarcinoma (65), which could be crucial to understand immunotherapy resistance (64, 66–68).